新冠后遗症：肺部并发症。
Post-COVID syndrome: pulmonary complications.
机构信息
Department of Chest Diseases, Faculty of Medicine, Başkent University, Ankara, Turkey
Department of Chest Diseases, Atatürk Chest Diseases and Thoracic Surgery Centre, Health Sciences University, Ankara, Tukey
出版信息
Turk J Med Sci. 2021 Dec 17;51(SI-1):3359-3371. doi: 10.3906/sag-2106-238.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease named as COVID-19, which is composed of multi systemic manifestations with a pulmonary system predominance. As the time passes, we are dealing more and more with a wide variety of effects and complications of the disease in survivors as far as with concerns about the clinical outcome and the timeline of symptoms in different patients. Since the lungs are the most involved organs and the post-COVID prolonged and persistent effects are mainly related to the pulmonary system, it is crucial to define and predict the outcome and to determine the individuals that can progress to fibrosis and loss of function of lungs. This review summarizes the current literature regarding the pulmonary complications in post-COVID syndrome and the management of these conditions.
严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）已在全球范围内感染了数百万人，并引发了一场仍在持续的大流行。该病毒可引起一种名为 COVID-19 的疾病，其由以肺部系统为主的多系统表现组成。随着时间的推移，我们越来越多地处理幸存者中疾病的各种影响和并发症，以及对不同患者的临床结果和症状时间线的担忧。由于肺部是最受影响的器官，而 COVID 后持续和持久的影响主要与肺部系统有关，因此定义和预测结局以及确定可能进展为纤维化和肺部功能丧失的个体至关重要。这篇综述总结了 COVID 后综合征中肺部并发症的现有文献以及这些疾病的管理。
Zotero 插件